HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The treatment of Peyronie's disease with tamoxifen.

Abstract
This is a preliminary study of the treatment of 36 patients with Peyronie's disease who received tamoxifen 20 mg twice daily for 3 months. An improvement occurred in 16 of 20 patients with penile pain, in 11 of 31 patients with an erectile deformity and 12 of 35 patients had a plaque shrinkage of at least 1 cm. Some improvement occurred in 6 of the 8 patients with a histologically confirmed inflammatory infiltrate of the plaque but not in any of the 4 patients without an infiltrate. The inflammatory infiltrate was found in patients in whom the duration of the disease was less than 4 months.
AuthorsD J Ralph, M D Brooks, G F Bottazzo, J P Pryor
JournalBritish journal of urology (Br J Urol) Vol. 70 Issue 6 Pg. 648-51 (Dec 1992) ISSN: 0007-1331 [Print] England
PMID1486392 (Publication Type: Journal Article)
Chemical References
  • Tamoxifen
Topics
  • Adult
  • Aged
  • Humans
  • Male
  • Middle Aged
  • Penile Induration (drug therapy, pathology)
  • Penis (pathology)
  • Tamoxifen (therapeutic use)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: